General


Peptide: SMAP-29
Microorganism:Stenotrophomonas maltophilia
Administration:
Stage: Formation (3-24h)
Notes:Sm109 clinical isolate

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Crystal violet assay > 90% 0.626 uM Sm109 strain
Crystal violet assay 51 - 90% 0.313 uM Sm143 strain
Crystal violet assay <= 20 % 0 uM Sm143 strain

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or giuseppe.maccari@iit.it